Similar articles for PMID: 31207878

Year	Number of Results
1975	1
1979	1
1980	1
1982	2
1983	1
1985	3
1986	1
1987	2
1988	2
1989	1
1990	2
1992	1
1993	1
1994	6
1996	1
1997	2
1998	3
2000	1
2001	1
2002	1
2003	2
2004	2
2005	5
2006	3
2007	5
2008	2
2009	3
2010	2
2011	5
2012	2
2013	4
2014	4
2016	3
2017	4
2018	4
2019	5
2020	1
2024	0

1

Novel 11-Substituted Ellipticines as Potent Anticancer Agents with Divergent Activity against Cancer Cells.

Miller CM, O'Sullivan EC, McCarthy FO. Miller CM, et al. Pharmaceuticals (Basel). 2019 Jun 14;12(2):90. doi: 10.3390/ph12020090. Pharmaceuticals (Basel). 2019. PMID: 31207878 Free PMC article.

2

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

Multon E, Riou JF, LeFevre D, Ahomadegbe JC, Riou G. Multon E, et al. Biochem Pharmacol. 1989 Jul 1;38(13):2077-86. doi: 10.1016/0006-2952(89)90060-9. Biochem Pharmacol. 1989. PMID: 2544183

3

Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.

Deane FM, O'Sullivan EC, Maguire AR, Gilbert J, Sakoff JA, McCluskey A, McCarthy FO. Deane FM, et al. Org Biomol Chem. 2013 Feb 28;11(8):1334-44. doi: 10.1039/c2ob27186a. Org Biomol Chem. 2013. PMID: 23314103

4

Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.

Vann KR, Ergün Y, Zencir S, Oncuoglu S, Osheroff N, Topcu Z. Vann KR, et al. Bioorg Med Chem Lett. 2016 Apr 1;26(7):1809-12. doi: 10.1016/j.bmcl.2016.02.034. Epub 2016 Feb 15. Bioorg Med Chem Lett. 2016. PMID: 26906637 Free PMC article.

5

Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.

Jurayj J, Haugwitz RD, Varma RK, Paull KD, Barrett JF, Cushman M. Jurayj J, et al. J Med Chem. 1994 Jul 8;37(14):2190-7. doi: 10.1021/jm00040a011. J Med Chem. 1994. PMID: 8035426

6

Synthesis and biological activity of 5-aza-ellipticine derivatives.

Moody DL, Dyba M, Kosakowska-Cholody T, Tarasova NI, Michejda CJ. Moody DL, et al. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2380-4. doi: 10.1016/j.bmcl.2006.09.093. Epub 2006 Oct 4. Bioorg Med Chem Lett. 2007. PMID: 17376678 Free PMC article.

7

Ellipticines as DNA-targeted chemotherapeutics.

Stiborová M, Frei E. Stiborová M, et al. Curr Med Chem. 2014;21(5):575-91. doi: 10.2174/09298673113206660272. Curr Med Chem. 2014. PMID: 24059226 Review.

8

Synthesis and biological evaluation of novel isoellipticine derivatives and salts.

Miller CM, O'Sullivan EC, Devine KJ, McCarthy FO. Miller CM, et al. Org Biomol Chem. 2012 Oct 21;10(39):7912-21. doi: 10.1039/c2ob26181b. Org Biomol Chem. 2012. PMID: 22940706

9

The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs.

Canals A, Purciolas M, Aymamí J, Coll M. Canals A, et al. Acta Crystallogr D Biol Crystallogr. 2005 Jul;61(Pt 7):1009-12. doi: 10.1107/S0907444905015404. Epub 2005 Jun 24. Acta Crystallogr D Biol Crystallogr. 2005. PMID: 15983425 Free article.

10

The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei.

Vilarem MJ, Riou JF, Multon E, Gras MP, Larsen CJ. Vilarem MJ, et al. Biochem Pharmacol. 1986 Jul 1;35(13):2087-95. doi: 10.1016/0006-2952(86)90575-7. Biochem Pharmacol. 1986. PMID: 3015146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year